Regardless that MDMB-FUBINACA is on the market around the globe through the net and also the abuse of the drug seems to be growing [1] there is little to no scientific/clinical details regarding the pharmacology, pharmacokinetics, biotransformation or toxicology from the drug. Animal reports of intraperitoneal (One more study finished on rats showe